Kyowa Kirin (KYKOF) Expected to Announce Earnings on Thursday

Kyowa Kirin (OTCMKTS:KYKOFGet Free Report) is projected to post its quarterly earnings results before the market opens on Thursday, February 6th. Analysts expect Kyowa Kirin to post earnings of $0.00 per share and revenue of $827.29 million for the quarter.

Kyowa Kirin Price Performance

OTCMKTS KYKOF opened at $14.80 on Wednesday. Kyowa Kirin has a one year low of $13.28 and a one year high of $22.21. The company has a 50-day simple moving average of $15.31 and a 200-day simple moving average of $17.84.

Kyowa Kirin Company Profile

(Get Free Report)

Kyowa Kirin Co, Ltd. engages in the research, development, manufacturing, marketing, and import/export of pharmaceuticals for oncology, nephrology, central nervous system, and immunology therapeutic areas in Japan, the United States, rest of the Americas, Europe, Asia, and internationally. Its products include ALLELOCK, an antihistamine agent for patients with various types of allergies; CONIEL, a calcium channel blocker for hypertension and angina pectoris; Crysvita, a recombinant human monoclonal IgG1 antibody against the phosphaturic hormone fibroblast growth factor 23; ESPO, a glycoprotein and human erythropoietin; NESP, an erythropoiesis stimulating agent; and GRAN, a human colony-stimulating factor.

Featured Articles

Receive News & Ratings for Kyowa Kirin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kyowa Kirin and related companies with MarketBeat.com's FREE daily email newsletter.